Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Immune-checkpoint inhibitor-induced bullous pemphigoid in patients with metastatic renal cell carcinoma: two case reports and systematic review of the literature. (PubMed, Acta Oncol) - Sep 10, 2026 - "ICI-associated BP is a rare but important irAE in metastatic RCC, often occurring after prolonged ICI exposure and potentially requiring treatment modification. Early recognition may improve multidisciplinary management." 
Checkpoint inhibition • Journal • Review • Bullous Pemphigoid • Dermatology • Dermatopathology • Genito-urinary Cancer • Immunology • Oncology • Renal Cell Carcinoma • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42714143
 
Fernanda Costa Svedman; Ioannis Zerdes; Katerina Chatzidionysiou; Magnus Lindskog; Natalia Kuzmina; Panagiotis Filis; Philip Curman; Åsa Krantz
 
Sep 10, 2026
 
Prev Next